Lv75
3230 积分 2022-08-30 加入
PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy
21天前
已完结
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
1个月前
已完结
迟发性运动障碍患者113例预后影响因素分析
1个月前
已完结
Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment
2个月前
已完结
Maintenance immunosuppression in myasthenia gravis
2个月前
已关闭
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2个月前
已完结
Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation
3个月前
已完结
Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
3个月前
已完结
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
4个月前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
4个月前
已完结
皖公网安备34019202002308
